Key result
Although modern radiotherapy techniques reduce heart doses, lymphoma survivors treated with mediastinal radiotherapy remain at increased risk for cardiovascular disease and require lifelong surveillance.
Why the study?
Despite changes in radiotherapy techniques, the heart remains an organ at risk and radiation-induced cardiovascular complications are increased long term in lymphoma patients.
Does mediastinal radiotherapy increase the risk of cardiovascular complications in patients with Hodgkin lymphoma?
Does mediastinal radiotherapy increase the risk of cardiovascular complications in patients with Hodgkin lymphoma?
Mediastinal radiotherapy for Hodgkin lymphoma carries a significant, dose-dependent risk of long-term cardiovascular complications, highlighting the need for modern dose-reduction techniques and lifelong cardiac surveillance.
Answers are grounded in this paper and cite their sources.
Supports continued surveillance in mediastinal radiotherapy recipients; extends literature on late effects but leaves ideal protocols unresolved.
Radiotherapy (RT) is the cornerstone component of the current successful treatment of Hodgkin lymphoma (HL). Although RT has been used alone to cure in most patients in decades, combined modality regimes are preferred in most HL patients currently, besides early-stage lymphocyte predominance HL and for selected patients with classical HL who have contraindications to chemotherapy. Although classic RT fields, doses, and techniques have fundamentally changed over the years, the heart is still an organ at risk, and patients with radiation-induced cardiovascular complications are increased in the long term. In this paper, we aimed to review literature about radiation-induced cardiotoxicity in lymphoma patients treated with mediastinal RT.
No takes yet. Share an insight, caveat, or question.
alaattin özen (2022) conducted a review in Hodgkin Lymphoma. Mediastinal Radiotherapy was evaluated. Although modern radiotherapy techniques reduce heart doses, lymphoma survivors treated with mediastinal radiotherapy remain at increased risk for cardiovascular disease and require lifelong surveillance.
Synapse has enriched 10 related papers. Consider them for comparative context: